UniProt ID | SNF8_HUMAN | |
---|---|---|
UniProt AC | Q96H20 | |
Protein Name | Vacuolar-sorting protein SNF8 | |
Gene Name | SNF8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 258 | |
Subcellular Localization | Cytoplasm. Endosome membrane. Nucleus . Late endosome membrane. Recruited to the endosome membrane to participate in vesicle formation. | |
Protein Description | Component of the endosomal sorting complex required for transport II (ESCRT-II), which is required for multivesicular body (MVB) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-II complex is probably involved in the recruitment of the ESCRT-III complex. The ESCRT-II complex may also play a role in transcription regulation by participating in derepression of transcription by RNA polymerase II, possibly via its interaction with ELL. Required for degradation of both endocytosed EGF and EGFR, but not for the EGFR ligand-mediated internalization. It is also required for the degradation of CXCR4. Required for the exosomal release of SDCBP, CD63 and syndecan. [PubMed: 22660413] | |
Protein Sequence | MHRRGVGAGAIAKKKLAEAKYKERGTVLAEDQLAQMSKQLDMFKTNLEEFASKHKQEIRKNPEFRVQFQDMCATIGVDPLASGKGFWSEMLGVGDFYYELGVQIIEVCLALKHRNGGLITLEELHQQVLKGRGKFAQDVSQDDLIRAIKKLKALGTGFGIIPVGGTYLIQSVPAELNMDHTVVLQLAEKNGYVTVSEIKASLKWETERARQVLEHLLKEGLAWLDLQAPGEAHYWLPALFTDLYSQEITAEEAREALP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Methylation | ----MHRRGVGAGAI ----CCCCCCCHHHH | 29.48 | 24129315 | |
13 | Ubiquitination | VGAGAIAKKKLAEAK CCHHHHHHHHHHHCH | 44.31 | 33845483 | |
14 | Ubiquitination | GAGAIAKKKLAEAKY CHHHHHHHHHHHCHH | 43.95 | - | |
20 | 2-Hydroxyisobutyrylation | KKKLAEAKYKERGTV HHHHHHCHHHHHCCC | 48.65 | - | |
21 | Phosphorylation | KKLAEAKYKERGTVL HHHHHCHHHHHCCCC | 25.73 | 20068231 | |
26 | Ubiquitination | AKYKERGTVLAEDQL CHHHHHCCCCCHHHH | 20.68 | 23000965 | |
27 | Ubiquitination | KYKERGTVLAEDQLA HHHHHCCCCCHHHHH | 5.48 | 22817900 | |
30 | Ubiquitination | ERGTVLAEDQLAQMS HHCCCCCHHHHHHHH | 41.97 | 23000965 | |
36 | Ubiquitination | AEDQLAQMSKQLDMF CHHHHHHHHHHHHHH | 4.49 | 32015554 | |
36 | Sulfoxidation | AEDQLAQMSKQLDMF CHHHHHHHHHHHHHH | 4.49 | 21406390 | |
38 (in isoform 1) | Ubiquitination | - | 49.92 | 21890473 | |
38 | Ubiquitination | DQLAQMSKQLDMFKT HHHHHHHHHHHHHHH | 49.92 | 21963094 | |
38 (in isoform 2) | Ubiquitination | - | 49.92 | 21890473 | |
44 (in isoform 2) | Ubiquitination | - | 29.84 | 21890473 | |
44 (in isoform 1) | Ubiquitination | - | 29.84 | 21890473 | |
44 | Ubiquitination | SKQLDMFKTNLEEFA HHHHHHHHHCHHHHH | 29.84 | 21906983 | |
45 | Ubiquitination | KQLDMFKTNLEEFAS HHHHHHHHCHHHHHH | 33.50 | 29967540 | |
53 | Acetylation | NLEEFASKHKQEIRK CHHHHHHHHHHHHHH | 51.93 | 25953088 | |
53 (in isoform 1) | Ubiquitination | - | 51.93 | 21890473 | |
53 (in isoform 2) | Ubiquitination | - | 51.93 | 21890473 | |
53 | Ubiquitination | NLEEFASKHKQEIRK CHHHHHHHHHHHHHH | 51.93 | 21906983 | |
55 | Ubiquitination | EEFASKHKQEIRKNP HHHHHHHHHHHHHCH | 54.05 | 22817900 | |
99 | Ubiquitination | GVGDFYYELGVQIIE CCCHHHHHHHHHHHH | 27.89 | 32015554 | |
113 | Ubiquitination | EVCLALKHRNGGLIT HHHHHHHHCCCCEEE | 29.32 | 23000965 | |
117 | Ubiquitination | ALKHRNGGLITLEEL HHHHCCCCEEEHHHH | 19.91 | 23000965 | |
120 | Phosphorylation | HRNGGLITLEELHQQ HCCCCEEEHHHHHHH | 32.91 | - | |
130 (in isoform 2) | Ubiquitination | - | 47.94 | 21890473 | |
130 | Ubiquitination | ELHQQVLKGRGKFAQ HHHHHHHCCCCCCCC | 47.94 | 23000965 | |
130 (in isoform 1) | Ubiquitination | - | 47.94 | 21890473 | |
132 | Ubiquitination | HQQVLKGRGKFAQDV HHHHHCCCCCCCCCC | 43.47 | 29967540 | |
134 (in isoform 2) | Ubiquitination | - | 35.84 | 21890473 | |
134 | Acetylation | QVLKGRGKFAQDVSQ HHHCCCCCCCCCCCH | 35.84 | 25953088 | |
134 | Ubiquitination | QVLKGRGKFAQDVSQ HHHCCCCCCCCCCCH | 35.84 | 23000965 | |
134 (in isoform 1) | Ubiquitination | - | 35.84 | 21890473 | |
149 | Ubiquitination | DDLIRAIKKLKALGT HHHHHHHHHHHHCCC | 51.58 | 29967540 | |
186 | Ubiquitination | DHTVVLQLAEKNGYV CCEEEEEEHHHCCEE | 6.09 | 32015554 | |
192 | Phosphorylation | QLAEKNGYVTVSEIK EEHHHCCEEEHHHHH | 11.44 | 28152594 | |
194 | Phosphorylation | AEKNGYVTVSEIKAS HHHCCEEEHHHHHHH | 15.16 | 28152594 | |
196 | Phosphorylation | KNGYVTVSEIKASLK HCCEEEHHHHHHHCC | 25.00 | 28152594 | |
201 | Phosphorylation | TVSEIKASLKWETER EHHHHHHHCCCCHHH | 26.02 | - | |
202 | Ubiquitination | VSEIKASLKWETERA HHHHHHHCCCCHHHH | 9.99 | 32015554 | |
203 | Ubiquitination | SEIKASLKWETERAR HHHHHHCCCCHHHHH | 40.25 | 32015554 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNF8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNF8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNF8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...